Scott R. Plotkin

16.1k citations

216 papers · 7.8k indexed · h-index 48

Impact in

Neurology top 0.1%
- Neurofibromatosis and Schwannoma Cases
- Vascular Malformations Diagnosis and Treatment
- Neuroblastoma Research and Treatments
Genetics top 0.5%
- Glioma Diagnosis and Treatment

Papers in ⓘ

Neurology 149
- Neurofibromatosis and Schwannoma Cases 135
- Vascular Malformations Diagnosis and Treatment 29
- Neuroblastoma Research and Treatments 17
Genetics 53
- Glioma Diagnosis and Treatment 53

Co-authors: Vanessa L. Merker (42 shared papers)Anat Stemmer‐Rachamimov (31 shared papers)Tracy T. Batchelor (26 shared papers)Abba J. Kastin (6 shared papers)William A. Banks (5 shared papers)Fred G. Barker (14 shared papers)Patrick Y. Wen (20 shared papers)Rakesh K. Jain (19 shared papers)
Journals: Neurology (27 papers)Journal of Clinical Oncology (23 papers)Neuro-Oncology (17 papers)Journal of Neuro-Oncology (13 papers)Otology & Neurotology (5 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Scott R. Plotkin

199 papers receiving 7.6k citations

Peers

Countries citing papers authored by Scott R. Plotkin

Since Specialization

Citations

This map shows the geographic impact of Scott R. Plotkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. Plotkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. Plotkin more than expected).

Fields of papers citing papers by Scott R. Plotkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. Plotkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. Plotkin. The network helps show where Scott R. Plotkin may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott R. Plotkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott R. Plotkin Line = papers co-authored together Scott R. Plotkin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma Journal of Clinical Oncology ·Tracy T. Batchelor, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Scott R. Plotkin, Elizabeth R. Gerstner, April F. Eichler, Jan Drappatz, Fred H. Hochberg, Thomas Benner, David N. Louis, Kenneth S. Cohen, Houng Chea, Alexis Exarhopoulos, Jay S. Loeffler, Marsha A. Moses, Percy Ivy, A. Gregory Sorensen, Patrick Y. Wen, Rakesh K. Jain	2010	406
2	Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme Journal of Clinical Oncology ·David A. Reardon, Karen Fink, Tom Mikkelsen, Timothy F. Cloughesy, A. O’Neill, Scott R. Plotkin, Michael Glantz, Paula Ravin, Jeffrey J. Raizer, Keith M. Rich, David Schiff, William R. Shapiro, Susan Burdette-Radoux, Edward J. Dropcho, Sabine M. Wittemer, Johannes Nippgen, Martin Picard, Burt Nabors	2008	377
3	Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. Journal of Pharmacology and Experimental Therapeutics ·William A. Banks, Luis A. Ortiz, Scott R. Plotkin, Abba J. Kastin	1991	374
4	Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2 New England Journal of Medicine ·Scott R. Plotkin, Anat Stemmer‐Rachamimov, Fred G. Barker, Chris Halpin, Timothy P. Padera, A. W. R. TYRRELL, A. Gregory Sorensen, Rakesh K. Jain, Emmanuelle di Tomaso	2009	325
5	Diagnostic criteria for schwannomatosis Neurology ·Mia MacCollin, E. Antonio Chiocca, D. Gareth Evans, Jan M. Friedman, R. Horvitz, Diego Jaramillo, Michael H. Lev, Victor F. Mautner, Michihito Niimura, Scott R. Plotkin, Christine N. Sang, Anat Stemmer‐Rachamimov, E. Steve Roach	2005	248
6	NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth Molecular and Cellular Biology ·Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh	2009	215
7	Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma Neuro-Oncology ·Thomas Kaley, Patrick Y. Wen, David Schiff, Keith L. Ligon, Sam Haidar, Sasan Karimi, Andrew B. Lassman, Craig Nolan, Lisa M. DeAngelis, Igor T. Gavrilovic, Andrew D. Norden, Jan Drappatz, Eudocia Q. Lee, Benjamin Purow, Scott R. Plotkin, Tracy T. Batchelor, Lauren E. Abrey, Antonio Omuro	2014	194
8	Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial Journal of Clinical Oncology ·Areej El‐Jawahri, Lisa Podgurski, April F. Eichler, Scott R. Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes	2009	194
9	Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma Neuro-Oncology ·Christine Lu‐Emerson, Matija Snuderl, Nathaniel D. Kirkpatrick, Jermaine Goveia, Christian J. Davidson, Yuhui Huang, Lars Riedemann, Justin Taylor, Percy Ivy, Dan G. Duda, Marek Ancukiewicz, Scott R. Plotkin, A. S., Elizabeth R. Gerstner, April F. Eichler, Jörg Dietrich, Anat Stemmer‐Rachamimov, Tracy T. Batchelor, R. K. Jain	2013	177
10	Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2 Otology & Neurotology ·Scott R. Plotkin, Vanessa L. Merker, Chris Halpin, Dominique Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker	2012	167
11	Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate Clinical Cancer Research ·Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, Burt Nabors, Brian Chon, Tracy T. Batchelor	2004	159
12	Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape Cancer Research ·Emmanuelle di Tomaso, Matija Snuderl, Walid S. Kamoun, Dan G. Duda, Pavan K. Auluck, Ladan Fazlollahi, Ovidiu C. Andronesi, Matthew P. Frosch, Patrick Y. Wen, Scott R. Plotkin, E. Tessa Hedley‐Whyte, A. Gregory Sorensen, Tracy T. Batchelor, Rakesh K. Jain	2011	156
13	Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients The Oncologist ·Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat Stemmer‐Rachamimov, Scott R. Plotkin	2012	144
14	Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria American Journal of Medical Genetics Part A ·Scott R. Plotkin, Jaishri O. Blakeley, D. Gareth Evans, C. Oliver Hanemann, Theo J.M. Hulsebos, Kim Hunter‐Schaedle, Ganjam V. Kalpana, Bruce R. Korf, Ludwine Messiaen, Laura Papi, Nancy Ratner, Larry S. Sherman, Miriam J. Smith, Anat Stemmer‐Rachamimov, Jérémie Vitte, Marco Giovannini	2013	117
15	Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis PLoS ONE ·Scott R. Plotkin, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Sonia Esparza, Vanessa L. Merker, Lance L. Munn, Alona Muzikansky, Manor Askenazi, Rosa Nguyen, Ralph Wenzel, Victor F. Mautner	2012	108
16	Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis Clinical Genetics ·C. D. Boyd, Miriam J. Smith, Lan Kluwe, A. Balogh, Mia MacCollin, Scott R. Plotkin	2008	106
17	Recommendations for imaging tumor response in neurofibromatosis clinical trials Neurology ·Eva Dombi, Simone Ardern‐Holmes, Dusica Babovic‐Vuksanovic, Fred G. Barker, Steve Connor, D. Gareth Evans, Michael J. Fisher, Stéphane Goutagny, Gordon J. Harris, Diego Jaramillo, Matthias A. Karajannis, Bruce R. Korf, Victor Mautner, Scott R. Plotkin, Tina Young Poussaint, Kent A. Robertson, Chie‐Schin Shih, Brigitte C. Widemann	2013	101
18	Genetic Causes of Brain Tumors: Neurofibromatosis, Tuberous Sclerosis, von Hippel-Lindau, and Other Syndromes Neurologic Clinics ·Christopher Farrell, Scott R. Plotkin	2007	88
19	Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas Journal of Clinical Oncology ·Jaishri O. Blakeley, Xiaobu Ye, Dan G. Duda, Chris Halpin, Amanda L. Bergner, Alona Muzikansky, Vanessa L. Merker, Elizabeth R. Gerstner, Laura M. Fayad, Shivani Ahlawat, Michael A. Jacobs, Rakesh K. Jain, Christopher Zalewski, Eva Dombi, Brigitte C. Widemann, Scott R. Plotkin	2016	86
20	Value of PET in the Assessment of Patients with Neurofibromatosis Type 1 American Journal of Roentgenology ·Miriam A. Bredella, Martin Torriani, Francis J. Hornicek, Hugue A. Ouellette, William E. Plamer, Ziv M. Williams, A.J. Fischman, Scott R. Plotkin	2007	86

About Scott R. Plotkin

Scott R. Plotkin is a scholar working on Neurology, Genetics, Epidemiology, Rheumatology and Pathology and Forensic Medicine, having authored 216 papers that have together received 7.8k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (135 papers), Meningioma and schwannoma management (83 papers), Glioma Diagnosis and Treatment (53 papers), Vascular Malformations Diagnosis and Treatment (29 papers), Sarcoma Diagnosis and Treatment (22 papers), Neuroblastoma Research and Treatments (17 papers), Chromatin Remodeling and Cancer (11 papers) and Soft tissue tumors and treatment (11 papers). The work is most often cited by research in Neurology (4.1k citations), Genetics (1.7k citations), Epidemiology (2.6k citations), Rheumatology (735 citations) and Pathology and Forensic Medicine (845 citations). Scott R. Plotkin has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Vanessa L. Merker, Anat Stemmer‐Rachamimov, Tracy T. Batchelor, Abba J. Kastin, William A. Banks, Fred G. Barker, Patrick Y. Wen, Rakesh K. Jain, Chris Halpin and Jaishri O. Blakeley. Their work appears in journals such as Neurology, Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology and Otology & Neurotology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact